---
title: "Top 5 HK Stock Gainers/Losers (>100B) (4.15)"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/282807934.md"
description: "SKB BIO(06990) rose 6.97%, with a trading turnover 458.1 Million HKD, and a year-to-date rose 32.3%. AKESO(09926) rose 6.89%, with a trading turnover 1.7 Billion HKD, and a year-to-date rose 30.4%. MINIMAX-W(00100) fell 10.88%, with a trading turnover 1.9 Billion HKD, and a year-to-date rose 413.6%. KNOWLEDGE ATLAS(02513) fell 8.54%, with a trading turnover 1.9 Billion HKD, and a year-to-date rose 646.1%."
datetime: "2026-04-15T08:30:41.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/282807934.md)
  - [en](https://longbridge.com/en/news/282807934.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/282807934.md)
---

# Top 5 HK Stock Gainers/Losers (>100B) (4.15)

Hang Seng Index has rose 0.29%, with a year-to-date rose 1.2%; Hang Seng TECH Index has rose 1.23%, with a year-to-date fell 11%.

SKB BIO(06990) rose 6.97%, with a trading turnover 458.1 Million HKD, and a year-to-date rose 32.3%.

AKESO(09926) rose 6.89%, with a trading turnover 1.7 Billion HKD, and a year-to-date rose 30.4%.

MINIMAX-W(00100) fell 10.88%, with a trading turnover 1.9 Billion HKD, and a year-to-date rose 413.6%.

KNOWLEDGE ATLAS(02513) fell 8.54%, with a trading turnover 1.9 Billion HKD, and a year-to-date rose 646.1%.

### Related Stocks

- [06990.HK](https://longbridge.com/en/quote/06990.HK.md)
- [09926.HK](https://longbridge.com/en/quote/09926.HK.md)
- [06181.HK](https://longbridge.com/en/quote/06181.HK.md)
- [01801.HK](https://longbridge.com/en/quote/01801.HK.md)
- [01177.HK](https://longbridge.com/en/quote/01177.HK.md)
- [00100.HK](https://longbridge.com/en/quote/00100.HK.md)
- [02513.HK](https://longbridge.com/en/quote/02513.HK.md)
- [03317.HK](https://longbridge.com/en/quote/03317.HK.md)
- [06869.HK](https://longbridge.com/en/quote/06869.HK.md)
- [01772.HK](https://longbridge.com/en/quote/01772.HK.md)

## Related News & Research

- [Sichuan Kelun-Biotech Wins HKEX Approval for Hong Kong Share Full Circulation](https://longbridge.com/en/news/282132765.md)
- [Sino Biopharmaceutical Enrolls First Patient in Heart Drug Study](https://longbridge.com/en/news/282276920.md)
- [Kelun-Biotech Commits RMB690 Million to Structured Deposits in Treasury Move](https://longbridge.com/en/news/282852295.md)
- [Xunce Technology to Partner With State-owned Enterprise on Data Assetization](https://longbridge.com/en/news/282475091.md)
- [Sino Biopharm enrolls first patient in Phase III LM-302 gastric cancer trial](https://longbridge.com/en/news/282812117.md)